Jennifer W Mack1, Kimberly Cannavale2, Olivia Sattayapiwat2, Bianca Cheung2, Lie H Chen2, Robert M Cooper3, Chun R Chao2. 1. 1 Division of Population Sciences, Department of Pediatric Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute , Boston, Massachusetts. 2. 2 Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California. 3. 3 Department of Pediatric Oncology, Kaiser Permanente Southern California, Pasadena, California.
Abstract
BACKGROUND: Little is known about the care that adolescent and young adult (AYA) patients with cancer receive at the end of life (EOL). OBJECTIVE: To examine care in the last month of life among AYA patients with cancer. DESIGN: Medical record review of the last 30 days of life. SETTING/ SUBJECTS: One hundred eleven AYA patients aged 15-39 years at death with either stage I-III cancer and evidence of cancer recurrence or stage IV cancer at diagnosis. Patients received care in Kaiser Permanente Southern California, an integrated healthcare delivery system, and died from 2007 to 2010. MEASUREMENTS: Use of intensive measures, including chemotherapy in the last 14 days of life and emergency room visits, hospitalizations, and intensive care unit admissions in the last 30 days; documented care preferences; symptom prevalence and treatment; advance care planning; hospice use; and location of death. RESULTS: One hundred seven patients (96%) had documented care preferences in the last month of life. At first documentation, 72% of patients wished for life-prolonging care, 20% wished for care focused on comfort, and 8% were undecided. Forty-seven percent of patients had documented changes in preferences in the last month, with 40% wishing for life-prolonging care when preferences were last noted before death, 56% preferring comfort, and 4% undecided. Seventy-eight percent of patients received at least one form of intensive EOL care, including 75% of those who preferred comfort measures at last documentation. CONCLUSIONS: Many AYA patients enter the last month of life wishing for life-prolonging care. While most ultimately wish for comfort, intensive care is prevalent even among such patients.
BACKGROUND: Little is known about the care that adolescent and young adult (AYA) patients with cancer receive at the end of life (EOL). OBJECTIVE: To examine care in the last month of life among AYA patients with cancer. DESIGN: Medical record review of the last 30 days of life. SETTING/ SUBJECTS: One hundred eleven AYA patients aged 15-39 years at death with either stage I-III cancer and evidence of cancer recurrence or stage IV cancer at diagnosis. Patients received care in Kaiser Permanente Southern California, an integrated healthcare delivery system, and died from 2007 to 2010. MEASUREMENTS: Use of intensive measures, including chemotherapy in the last 14 days of life and emergency room visits, hospitalizations, and intensive care unit admissions in the last 30 days; documented care preferences; symptom prevalence and treatment; advance care planning; hospice use; and location of death. RESULTS: One hundred seven patients (96%) had documented care preferences in the last month of life. At first documentation, 72% of patients wished for life-prolonging care, 20% wished for care focused on comfort, and 8% were undecided. Forty-seven percent of patients had documented changes in preferences in the last month, with 40% wishing for life-prolonging care when preferences were last noted before death, 56% preferring comfort, and 4% undecided. Seventy-eight percent of patients received at least one form of intensive EOL care, including 75% of those who preferred comfort measures at last documentation. CONCLUSIONS: Many AYA patients enter the last month of life wishing for life-prolonging care. While most ultimately wish for comfort, intensive care is prevalent even among such patients.
Authors: Jennifer W Mack; Lie H Chen; Kimberley Cannavale; Olivia Sattayapiwat; Robert M Cooper; Chun R Chao Journal: JAMA Oncol Date: 2015-08 Impact factor: 31.777
Authors: Craig C Earle; Ann B Nattinger; Arnold L Potosky; Kathleen Lang; Rajiv Mallick; Mark Berger; Joan L Warren Journal: Med Care Date: 2002-08 Impact factor: 2.983
Authors: Peter F Coccia; Jessica Altman; Smita Bhatia; Scott C Borinstein; Joseph Flynn; Suzanne George; Robert Goldsby; Robert Hayashi; Mary S Huang; Rebecca H Johnson; Lynda Kwon Beaupin; Michael P Link; Kevin C Oeffinger; Kathleen M Orr; Alberto S Pappo; Damon Reed; Holly L Spraker; Deborah A Thomas; Margaret von Mehren; Daniel S Wechsler; Kimberly F Whelan; Bradley J Zebrack; Hema Sundar; Dorothy A Shead Journal: J Natl Compr Canc Netw Date: 2012-09 Impact factor: 11.908
Authors: Giselle K Perez; John M Salsman; Kaitlyn Fladeboe; Anne C Kirchhoff; Elyse R Park; Abby R Rosenberg Journal: Am Soc Clin Oncol Educ Book Date: 2020-03
Authors: Ursula M Sansom-Daly; Claire E Wakefield; Pandora Patterson; Richard J Cohn; Abby R Rosenberg; Lori Wiener; Joanna E Fardell Journal: J Adolesc Young Adult Oncol Date: 2019-10-29 Impact factor: 2.223
Authors: Sarah Friebert; Daniel H Grossoehme; Justin N Baker; Jennifer Needle; Jessica D Thompkins; Yao I Cheng; Jichuan Wang; Maureen E Lyon Journal: JAMA Netw Open Date: 2020-05-01
Authors: Anthony R Kerlavage; Anne C Kirchhoff; Jaime M Guidry Auvil; Norman E Sharpless; Kara L Davis; Karlyne Reilly; Gregory Reaman; Lynne Penberthy; Dennis Deapen; Amie Hwang; Eric B Durbin; Sara L Gallotto; Richard Aplenc; Samuel L Volchenboum; Allison P Heath; Bruce J Aronow; Jinghui Zhang; Olena Vaske; Todd A Alonzo; Paul C Nathan; Jenny N Poynter; Greg Armstrong; Erin E Hahn; Karen J Wernli; Casey Greene; Jack DiGiovanna; Adam C Resnick; Eve R Shalley; Sorena Nadaf; Warren A Kibbe Journal: JCO Clin Cancer Inform Date: 2021-08